Helen Collins

National Institute for Health and Care Research

Also affiliated with NIHR Research Delivery Network, Clinical Research Network Thames Valley and South Midlands

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 2 papers. Top paper: “Randomized double-blind placebo-controlled phase 2 study of bemarituzumab combined with modified FOLFOX6 (mFOLFOX6) in first-line (1L) treatment of advanced gastric/gastroesophageal junction adenocarcinoma (FIGHT).”.

Randomized double-blind placebo-controlled phase 2 study of bemarituzumab combined with modified FOLFOX6 (mFOLFOX6) in first-line (1L) treatment of advanced gastric/gastroesophageal junction adenocarcinoma (FIGHT).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.3_suppl.160

N/A

0.652DataRank · unranked

76 citations

Peter C. Enzinger, Yoon-Koo Kang, Kensei Yamaguchi, Shukui Qin, Keun-Wook Lee +11 more

Predictors of the experience of a Cytosponge test: analysis of patient survey data from the BEST3 trial

BMC Gastroenterology(2023)10.1186/s12876-022-02630-1

N/A

0.173DataRank · unranked

2 citations

Rebecca Landy, Roberta Maroni, Samuel G. Smith, Irene Debiram–Beecham, Peter Sasieni +56 more